BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 29, 2008
View Archived Issues
Once-yearly Aclasta recommended for approval in E.U. for male osteoporosis
Read More
CombinatoRx presents an update on the company's activities
Read More
Recent patents disclose novel antiinflammatory agents
Read More
Novel treatment options for autoimmune diseases reported by AstraZeneca
Read More
Novel treatments for hepatitis C virus infection disclosed in recent patents
Read More
Raltegravir clinically effective in a triple-class drug resistance HIV-1 infection
Read More
Aeras to fund phase IIb clinical trials of AERAS-485/MVA-85A TB vaccine
Read More
First-in-human results with [11C]-GSK-215083 radioligand in imaging brain 5-HT6 receptor
Read More
[11C]-(+)-RX-821024, a promising novel tracer for imaging alpha2-adrenoceptors
Read More
Novel marker [18F]-AH-110690 tested in humans for the detection of early-stage Alzheimer's disease
Read More
Alexza initiates second phase III clinical trial of Staccato for acute agitation in schizophrenia
Read More
First-in-human results of Alzheimer's disease vaccine CAD-106
Read More
GSK and HSCI sign collaborative agreement in stem cell science
Read More
MacroChem reports phase II data for EcoNail in onychomycosis
Read More
Nabi presents positive interim results of NicVAX immunogenicity study
Read More
NicOx reports top-line results from naproxcinod 52-week 301 safety extension
Read More
Sound Pharmaceuticals files IND with FDA for SPI-3005 for ototoxicity
Read More
NuPathe raises USD 30 million in series B equity financing
Read More
FDA grants Ortho-McNeil pediatric exclusivity for Topamax
Read More
BioCryst's phase II peramivir study meets primary endpoint in influenza
Read More
Exforge shown to effectively control blood pressure
Read More
Innocoll doses first patient in third U.S. phase II CollaRx bupivacaine surgical implant trial
Read More
Nventa reports final data from HspE7 phase I cervical dysplasia trial
Read More
OP-145 found effective in phase II ear infection study
Read More
Sucampo initiates phase II cobiprostone trial in portal hypertension
Read More